Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Biophytis ADR Representing 4000 Ord Shs BPTSY

Healthcare Biotechnology
Biophytis SA, formerly Institut Biophytis Sas is a France-based company engaged in the healthcare industry. The Company is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.


OTCPK:BPTSY - Post by User

Biophytis ADR Representing 4000 Ord Shs
Bullboard Posts
Next >>
User Avatar Image
(217)
•••
Post by askretkaon Dec 17, 2023 9:27pm
185 Views
Post# 35789137

Up over 30% Friday Repairs lungs after COVID-19

Up over 30% Friday Repairs lungs after COVID-19 Lots of chatter on this one , pretty speculative but probably going to attract lots of swing traders and such?

Bought a position two weeks ago at $ 0 .77 US been pretty quiet since then until now.

Helps with lung repair after COVID-19 and Flu infection?

Possible use for people who loose too much lean muscle by over use of drugs like Ozempic.

Possible anti aging drug to help build up lean muscle mass in aging.

Just all I have, been too busy lately.

Cheers!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities